InvestorsHub Logo
Post# of 253525
Next 10
Followers 36
Posts 1736
Boards Moderated 0
Alias Born 05/13/2011

Re: None

Monday, 03/27/2017 3:47:27 PM

Monday, March 27, 2017 3:47:27 PM

Post# of 253525
TESARO Announces Expanded Development Program for Niraparib Focused on the Treatment of Front-Line Metastatic Ovarian and Lung Cancers and Metastatic Breast Cancer

http://ir.tesarobio.com/releasedetail.cfm?ReleaseID=1018917
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.